Vascular metabolism of anandamide to arachidonic acid affects myogenic constriction in response to intraluminal pressure elevation

Ágnes Czikora, Erzsébet Lizanecz, Judit Boczán, Andrea Daragó, Z. Papp, I. Édes, Attila Tóth

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Aims: We hypothesized that arachidonic acid produced by anandamide breakdown contributes to the vascular effects of anandamide. Main methods: Isolated, pressurized rat skeletal muscle arteries, which possess spontaneous myogenic tone, were treated with anandamide, arachidonic acid, capsaicin (vanilloid receptor agonist), WIN 55-212-2 (cannabinoid receptor agonist), URB-597 (FAAH inhibitor), baicalein (lipoxygenase inhibitor), PPOH (cytochrome P450 inhibitor), and indomethacin (cyclooxygenase inhibitor). Changes in the arteriolar diameter in response to the various treatments were measured. To assess the effect of anandamide metabolism, anandamide was applied for 20 min followed by washout for 40 min. This protocol was used to eliminate other, more direct effects of anandamide in order to reveal how anandamide metabolism may influence vasodilation. Key findings: Anandamide at a low dose (1 μM) evoked a loss of myogenic tone, while a high dose (30 μM) not only attenuated the myogenic response but also evoked acute dilation. Both of these effects were inhibited by the FAAH inhibitor URB-597 and were mimicked by arachidonic acid. The CB1 and CB2 agonist R-WIN 55-212-2 and the vanilloid receptor agonist capsaicin were without effect on the myogenic response. The inhibition of the myogenic response by anandamide was blocked by indomethacin and PPOH, but not by baicalein or removal of the endothelium. FAAH expression in the smooth muscle cells of the blood vessels was confirmed by immunohistochemistry. Significance: Anandamide activates the arachidonic acid pathway in the microvasculature, affecting vascular autoregulation (myogenic response) and local perfusion.

Original languageEnglish
Pages (from-to)407-415
Number of pages9
JournalLife Sciences
Volume90
Issue number11-12
DOIs
Publication statusPublished - Mar 10 2012

Fingerprint

Arachidonic Acid
Metabolism
Constriction
Blood Vessels
Pressure
TRPV Cation Channels
Capsaicin
Indomethacin
Muscle
anandamide
Cannabinoid Receptor Agonists
Lipoxygenase Inhibitors
Cyclooxygenase Inhibitors
Blood vessels
Microvessels
Vasodilation
Cytochrome P-450 Enzyme System
Smooth Muscle Myocytes
Endothelium
Rats

Keywords

  • Anandamide
  • Arachidonic acid
  • Cannabinoid receptor
  • Myogenic response
  • Resistance artery
  • Vanilloid receptor (TRPV1)
  • Vascular autoregulation
  • Vasodilation

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Vascular metabolism of anandamide to arachidonic acid affects myogenic constriction in response to intraluminal pressure elevation. / Czikora, Ágnes; Lizanecz, Erzsébet; Boczán, Judit; Daragó, Andrea; Papp, Z.; Édes, I.; Tóth, Attila.

In: Life Sciences, Vol. 90, No. 11-12, 10.03.2012, p. 407-415.

Research output: Contribution to journalArticle

Czikora, Ágnes ; Lizanecz, Erzsébet ; Boczán, Judit ; Daragó, Andrea ; Papp, Z. ; Édes, I. ; Tóth, Attila. / Vascular metabolism of anandamide to arachidonic acid affects myogenic constriction in response to intraluminal pressure elevation. In: Life Sciences. 2012 ; Vol. 90, No. 11-12. pp. 407-415.
@article{81c364eba2944c73a77376b6e3663120,
title = "Vascular metabolism of anandamide to arachidonic acid affects myogenic constriction in response to intraluminal pressure elevation",
abstract = "Aims: We hypothesized that arachidonic acid produced by anandamide breakdown contributes to the vascular effects of anandamide. Main methods: Isolated, pressurized rat skeletal muscle arteries, which possess spontaneous myogenic tone, were treated with anandamide, arachidonic acid, capsaicin (vanilloid receptor agonist), WIN 55-212-2 (cannabinoid receptor agonist), URB-597 (FAAH inhibitor), baicalein (lipoxygenase inhibitor), PPOH (cytochrome P450 inhibitor), and indomethacin (cyclooxygenase inhibitor). Changes in the arteriolar diameter in response to the various treatments were measured. To assess the effect of anandamide metabolism, anandamide was applied for 20 min followed by washout for 40 min. This protocol was used to eliminate other, more direct effects of anandamide in order to reveal how anandamide metabolism may influence vasodilation. Key findings: Anandamide at a low dose (1 μM) evoked a loss of myogenic tone, while a high dose (30 μM) not only attenuated the myogenic response but also evoked acute dilation. Both of these effects were inhibited by the FAAH inhibitor URB-597 and were mimicked by arachidonic acid. The CB1 and CB2 agonist R-WIN 55-212-2 and the vanilloid receptor agonist capsaicin were without effect on the myogenic response. The inhibition of the myogenic response by anandamide was blocked by indomethacin and PPOH, but not by baicalein or removal of the endothelium. FAAH expression in the smooth muscle cells of the blood vessels was confirmed by immunohistochemistry. Significance: Anandamide activates the arachidonic acid pathway in the microvasculature, affecting vascular autoregulation (myogenic response) and local perfusion.",
keywords = "Anandamide, Arachidonic acid, Cannabinoid receptor, Myogenic response, Resistance artery, Vanilloid receptor (TRPV1), Vascular autoregulation, Vasodilation",
author = "{\'A}gnes Czikora and Erzs{\'e}bet Lizanecz and Judit Bocz{\'a}n and Andrea Darag{\'o} and Z. Papp and I. {\'E}des and Attila T{\'o}th",
year = "2012",
month = "3",
day = "10",
doi = "10.1016/j.lfs.2011.12.016",
language = "English",
volume = "90",
pages = "407--415",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "11-12",

}

TY - JOUR

T1 - Vascular metabolism of anandamide to arachidonic acid affects myogenic constriction in response to intraluminal pressure elevation

AU - Czikora, Ágnes

AU - Lizanecz, Erzsébet

AU - Boczán, Judit

AU - Daragó, Andrea

AU - Papp, Z.

AU - Édes, I.

AU - Tóth, Attila

PY - 2012/3/10

Y1 - 2012/3/10

N2 - Aims: We hypothesized that arachidonic acid produced by anandamide breakdown contributes to the vascular effects of anandamide. Main methods: Isolated, pressurized rat skeletal muscle arteries, which possess spontaneous myogenic tone, were treated with anandamide, arachidonic acid, capsaicin (vanilloid receptor agonist), WIN 55-212-2 (cannabinoid receptor agonist), URB-597 (FAAH inhibitor), baicalein (lipoxygenase inhibitor), PPOH (cytochrome P450 inhibitor), and indomethacin (cyclooxygenase inhibitor). Changes in the arteriolar diameter in response to the various treatments were measured. To assess the effect of anandamide metabolism, anandamide was applied for 20 min followed by washout for 40 min. This protocol was used to eliminate other, more direct effects of anandamide in order to reveal how anandamide metabolism may influence vasodilation. Key findings: Anandamide at a low dose (1 μM) evoked a loss of myogenic tone, while a high dose (30 μM) not only attenuated the myogenic response but also evoked acute dilation. Both of these effects were inhibited by the FAAH inhibitor URB-597 and were mimicked by arachidonic acid. The CB1 and CB2 agonist R-WIN 55-212-2 and the vanilloid receptor agonist capsaicin were without effect on the myogenic response. The inhibition of the myogenic response by anandamide was blocked by indomethacin and PPOH, but not by baicalein or removal of the endothelium. FAAH expression in the smooth muscle cells of the blood vessels was confirmed by immunohistochemistry. Significance: Anandamide activates the arachidonic acid pathway in the microvasculature, affecting vascular autoregulation (myogenic response) and local perfusion.

AB - Aims: We hypothesized that arachidonic acid produced by anandamide breakdown contributes to the vascular effects of anandamide. Main methods: Isolated, pressurized rat skeletal muscle arteries, which possess spontaneous myogenic tone, were treated with anandamide, arachidonic acid, capsaicin (vanilloid receptor agonist), WIN 55-212-2 (cannabinoid receptor agonist), URB-597 (FAAH inhibitor), baicalein (lipoxygenase inhibitor), PPOH (cytochrome P450 inhibitor), and indomethacin (cyclooxygenase inhibitor). Changes in the arteriolar diameter in response to the various treatments were measured. To assess the effect of anandamide metabolism, anandamide was applied for 20 min followed by washout for 40 min. This protocol was used to eliminate other, more direct effects of anandamide in order to reveal how anandamide metabolism may influence vasodilation. Key findings: Anandamide at a low dose (1 μM) evoked a loss of myogenic tone, while a high dose (30 μM) not only attenuated the myogenic response but also evoked acute dilation. Both of these effects were inhibited by the FAAH inhibitor URB-597 and were mimicked by arachidonic acid. The CB1 and CB2 agonist R-WIN 55-212-2 and the vanilloid receptor agonist capsaicin were without effect on the myogenic response. The inhibition of the myogenic response by anandamide was blocked by indomethacin and PPOH, but not by baicalein or removal of the endothelium. FAAH expression in the smooth muscle cells of the blood vessels was confirmed by immunohistochemistry. Significance: Anandamide activates the arachidonic acid pathway in the microvasculature, affecting vascular autoregulation (myogenic response) and local perfusion.

KW - Anandamide

KW - Arachidonic acid

KW - Cannabinoid receptor

KW - Myogenic response

KW - Resistance artery

KW - Vanilloid receptor (TRPV1)

KW - Vascular autoregulation

KW - Vasodilation

UR - http://www.scopus.com/inward/record.url?scp=84858073338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858073338&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2011.12.016

DO - 10.1016/j.lfs.2011.12.016

M3 - Article

VL - 90

SP - 407

EP - 415

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 11-12

ER -